001065.KS

JW Pharmaceutical Corporation [001065.KS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

001065.KS Stock Summary

Top 10 Correlated Stocks

001065.KS


In the News

001065.KS Financial details

Company Rating
Strong Buy
Market Cap
764.84B
Income
37.83B
Revenue
701.39B
Book val./share
-
Cash/share
-
Dividend
388.35
Dividend %
1.23%
Employees
1.13K
Optionable
No
Shortable
Yes
Earnings
-
P/E
87.46
Forward P/E
-
PEG
-1.2
P/S
1.09
P/B
13.32
P/C
-
P/FCF
27.14
Quick Ratio
0.35
Current Ratio
1.08
Debt / Equity
1.13
LT Debt / Equity
0.12
-
-
EPS (TTM)
86.39
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
4.96%
Revenue Q/Q
-10.24%
EPS Q/Q
-
-
-
-
-
SMA20
-1.46%
SMA50
2.77%
SMA100
0.07%
Inst Own
-
Inst Trans
-
ROA
6%
ROE
17%
ROC
0.25%
Gross Margin
43%
Oper. Margin
10%
Profit Margin
5%
Payout
-
Shs Outstand
24.32M
Shs Float
13.9M
-
-
-
-
Target Price
-
52W Range
28900.0-38400.0
52W High
-18.1%
52W Low
+8.82%
RSI
39.84
Rel Volume
0.87
Avg Volume
261
Volume
228
Perf Week
-1.72%
Perf Month
-0.79%
Perf Quarter
-10.53%
Perf Half Y
-9.24%
-
-
-
-
Beta
0.252724
-
-
Volatility
231.23%, 343.29%
Prev Close
0.32%
Price
31450
Change
0.32%

001065.KS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
Revenue per share
22.09K005.78K0
Net income per share
331.300-13.740
Operating cash flow per share
2.14K00172.780
Free cash flow per share
1.8K0049.790
Cash per share
1.27K00625.990
Book value per share
10.7K001.92K0
Tangible book value per share
10.07K001.59K0
Share holders equity per share
10.7K001.92K0
Interest debt per share
7.56K002.41K0
Market cap
579.95B003566.57B0
Enterprise value
724.23B145.66B171.77B3778.34B175.64B
P/E ratio
71.9800-2.47K0
Price to sales ratio
1.08005.880
POCF ratio
11.1300196.790
PFCF ratio
13.2500682.940
P/B Ratio
2.230017.730
PTB ratio
2.230017.730
EV to sales
1.350.280.316.230.26
Enterprise value over EBITDA
19.79-58.6311.2979.742.13
EV to operating cash flow
13.92.622.72208.473.09
EV to free cash flow
16.553.433.58723.493.95
Earnings yield
0.010000
Free cash flow yield
0.080000
Debt to equity
0.670.820.881.220.87
Debt to assets
0.30.330.330.390.33
Net debt to EBITDA
3.94-58.6311.294.472.13
Current ratio
1.641.211.281.31.12
Interest coverage
2.48-1.69-0.724.256.71
Income quality
6.47-2.2-4.13-12.571.9
Dividend Yield
0.010000
Payout ratio
0.81-0.27-0.46-4.960.23
Sales general and administrative to revenue
0.120.080.120.140.13
Research and developement to revenue
0.040.050.040.030.05
Intangibles to total assets
0.030.040.030.030.03
Capex to operating cash flow
-0.16-0.24-0.24-0.71-0.22
Capex to revenue
-0.02-0.03-0.03-0.02-0.02
Capex to depreciation
-0.47-0.64-0.73-0.8-0.73
Stock based compensation to revenue
00000
Graham number
8.93K00770.070
ROIC
0.03-0.03-0.0100.09
Return on tangible assets
0.01-0.05-0.0300.05
Graham Net
-10.36K00-3.12K0
Working capital
145.54B57.07B64.58B83.77B45.33B
Tangible asset value
244.97B208.7B189.8B167.07B209.49B
Net current asset value
40.23B-8.06B-42.29B-78.06B23.24B
Invested capital
0.670.820.881.220.87
Average receivables
00000
Average payables
52.03B44.78B46.49B49.76B67.28B
Average inventory
104B95.9B95.82B101.86B107.1B
Days sales outstanding
00000
Days payables outstanding
47.7146.9947.2650.6476.34
Days of inventory on hand
108.7894.2699.88100.54102.82
Receivables turnover
00000
Payables turnover
7.657.777.727.214.78
Inventory turnover
3.363.873.653.633.55
ROE
0.03-0.11-0.07-0.010.13
Capex per share
-343.1500-122.990

Quarterly Fundamentals Overview

Last date of statement is 2023-03-31 for Q1

Metric History 2022-03-312022-06-302022-09-302022-12-31 2023-03-31
Revenue per share
1.49K1.57K1.61K00
Net income per share
91.099.3478.800
Operating cash flow per share
54.8987.58173.4300
Free cash flow per share
18.866.33140.5200
Cash per share
659.84662.591.39K00
Book value per share
1.93K1.95K2.04K00
Tangible book value per share
1.62K1.63K1.72K00
Share holders equity per share
1.93K1.95K2.04K00
Interest debt per share
2.42K2.34K2.22K00
Market cap
3982.43B3824.6B3530B00
Enterprise value
4201.06B4033.7B3725.91B175.64B257.86B
P/E ratio
103.88973.45106.4400
Price to sales ratio
25.4723.1820.7800
POCF ratio
689.53415.05193.4500
PFCF ratio
2.01K548.02238.7500
P/B Ratio
19.5818.6616.4800
PTB ratio
19.5818.6616.4800
EV to sales
26.8724.4521.940.911.49
Enterprise value over EBITDA
237.31275.12194.945.663.4
EV to operating cash flow
727.39437.74204.197.471.04K
EV to free cash flow
2.12K577.982528.5-18.09
Earnings yield
00000
Free cash flow yield
00000
Debt to equity
1.241.191.080.871.13
Debt to assets
0.40.390.370.330.42
Net debt to EBITDA
12.3514.2610.255.663.4
Current ratio
1.461.521.221.121.08
Interest coverage
5.643.394.4217.57-37.06
Income quality
0.6110.832.242.060.02
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.140.140.130.120.32
Research and developement to revenue
0.040.040.050.060.04
Intangibles to total assets
0.030.030.030.030.03
Capex to operating cash flow
-0.66-0.24-0.19-0.12-58.29
Capex to revenue
-0.02-0.01-0.02-0.01-0.08
Capex to depreciation
-0.81-0.56-0.85-0.7-2.18
Stock based compensation to revenue
00000
Graham number
1.99K639.631.9K00
ROIC
0.0200.020.040.03
Return on tangible assets
0.0200.010.020.02
Graham Net
-3.06K-2.92K-2.1K00
Working capital
117.4B124.64B74.31B45.33B31.14B
Tangible asset value
170.23B171.8B180.88B209.49B211.46B
Net current asset value
-74.59B-68.51B-7.71B23.24B-18.59B
Invested capital
1.241.191.080.871.13
Average receivables
00000
Average payables
53B56.49B57.04B69.19B71.26B
Average inventory
104.81B109.29B110.96B111.05B115.32B
Days sales outstanding
00000
Days payables outstanding
53.1452.8449.8571.554.94
Days of inventory on hand
104.7100.5199.2496.3109.68
Receivables turnover
00000
Payables turnover
1.691.71.811.261.64
Inventory turnover
0.860.90.910.930.82
ROE
0.0500.040.050.06
Capex per share
-36.09-21.25-32.9100

001065.KS Frequently Asked Questions

What is JW Pharmaceutical Corporation stock symbol ?

JW Pharmaceutical Corporation is a KR stock and trading under the symbol 001065.KS

What is JW Pharmaceutical Corporation stock quote today ?

JW Pharmaceutical Corporation stock price is $31450 today.

Is JW Pharmaceutical Corporation stock public?

Yes, JW Pharmaceutical Corporation is a publicly traded company.

Something similar

Top by Market Cap
Same Sector
Top Correlated Stocks
Similar Market Cap